Pharming Group NV (PHAR) — Cash Flow Quality Index
Latest as of December 2025:
1.40x
Pharming Group NV (PHAR) has a Cash Flow Quality Index of 1.40x as of December 2025. Operating cash flow of $7.39 Million exceeds net income of $5.29 Million, indicating high earnings quality where cash backs reported profits. Explore Pharming Group NV (PHAR) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
1.40x
Operating CF / Net Income
Operating Cash Flow
$7.39 Million
USD
Net Income
$5.29 Million
USD
Data as of
Dec 2025
Most recent filing
Pharming Group NV Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Pharming Group NV across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see PHAR cash flow conversion.
Annual Cash Flow Quality Index for Pharming Group NV (2017–2025)
Year-by-year earnings quality comparison for Pharming Group NV.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 17.51x | $50.07 Million | $2.86 Million | ▲ +1068.6% |
| 2022 | 1.50x | $22.46 Million | $14.99 Million | ▼ -8.6% |
| 2021 | 1.64x | $37.84 Million | $23.08 Million | ▼ -13.5% |
| 2020 | 1.90x | $83.63 Million | $44.09 Million | ▲ +33.8% |
| 2019 | 1.42x | $74.15 Million | $52.30 Million | ▲ +33.4% |
| 2018 | 1.06x | $46.19 Million | $43.46 Million | ▼ -39.1% |
| 2017 | 1.74x | $45.84 Million | $26.29 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.